Evidence map›Paper›PMID 23100476›Full record

ReviewClinical and vaccine immunology : CVI2012

Antibody responses to mycobacterial antigens in children with tuberculosis: challenges and potential diagnostic value.

Jacqueline M Achkar, Anke Ziegenbalg

Open access · diamondAbstract readReview
In one paragraph

Review in Clinical and vaccine immunology : CVI, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Antibodies as clinical tools for tuberculosis.Frontiers in immunology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Serologic Responses in Childhood Pulmonary Tuberculosis.The Pediatric infectious disease journal · 2018
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jacqueline M AchkarDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA. jacqueline.achkar@einstein.yu.edu
Anke Ziegenbalg
Albert Einstein College of Medicine · US

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
Antibody Biomarkers for Early Detection of TuberculosisR01AI096213 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MAGEE, D MITCHELL · 2011 to 2012
$1.0M
Immunodiagnostic Tests for the Rapid Diagnosis of TbK23AI067665 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI ACHKAR, JACQUELINE MICHELE · 2007 to 2011
$666k
NIAID NIH HHS AI-067665NIAID NIH HHS AI-096213NIAID NIH HHS AI-51519NIAID NIH HHS K23 AI067665NIAID NIH HHS P30 AI051519NIAID NIH HHS R01 AI096213
6 · The paper itself

Abstract

The identification of easily detectable biomarkers for active tuberculosis (TB) is a global health priority. Such biomarkers would be of particular value in childhood TB, which poses greater diagnostic challenges than adult TB. Serum antibodies can be detected by simple formats that provide extremely rapid results. However, attempts to develop accurate serodiagnostic tests for TB have been unsuccessful. Whereas antibody responses to mycobacterial antigens in adult TB have been studied extensively and reviewed, the same cannot be said for serologic data in pediatric populations. Here we appraise studies on serological responses in childhood TB and discuss findings and limitations in the context of the developing immune system, the age range, and the spectrum of TB manifestations. We found that the antibody responses to mycobacterial antigens in childhood TB can vary widely, with sensitivities and specificities ranging from 14% to 85% and from 86% to 100%, respectively. We conclude that the limitations in serodiagnostic studies of childhood TB are manifold, thereby restricting the interpretation of currently available data. Concerns about the methodology used in published studies suggest that conclusions about the eventual value of serodiagnosis cannot be made at this time. However, the available data suggest a potential adjunctive value for serology in the diagnosis of childhood TB. Despite the difficulties noted in this field, there is optimism that the application of novel antigens and the integration of those factors which contribute to the serological responses in childhood TB can lead to useful future diagnostics.

Indexed as

Antibody FormationAdolescentAntibodies, BacterialAntigens, BacterialChildChild, PreschoolHumansInfantInfant, NewbornMycobacterium tuberculosisSensitivity and SpecificitySerologic TestsTuberculosisAntibodies, BacterialAntigens, Bacterial

Identifiers

PMID23100476
PMCPMC3535867
OpenAlexW2125383351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.